National Drug Codes - Thalomid Revlimid
|
Proprietary Name |
Product NDC |
NDC Package Code |
Strength |
Dosage Form |
Route |
Appl. No. |
Labeler Name |
Nonproprietary Name |
Substance Name |
|
Thalomid |
59572-205 |
59572-205-94 |
50 mg/1 |
CAPSULE |
ORAL |
NDA020785 |
Celgene Corp. |
Thalidomide |
THALIDOMIDE |
|
Thalomid |
59572-205 |
59572-205-97 |
50 mg/1 |
CAPSULE |
ORAL |
NDA020785 |
Celgene Corp. |
Thalidomide |
THALIDOMIDE |
|
Thalomid |
59572-210 |
59572-210-95 |
100 mg/1 |
CAPSULE |
ORAL |
NDA020785 |
Celgene Corp. |
Thalidomide |
THALIDOMIDE |
|
Thalomid |
59572-215 |
59572-215-93 |
150 mg/1 |
CAPSULE |
ORAL |
NDA020785 |
Celgene Corp. |
Thalidomide |
THALIDOMIDE |
|
Thalomid |
59572-220 |
59572-220-96 |
200 mg/1 |
CAPSULE |
ORAL |
NDA020785 |
Celgene Corp. |
Thalidomide |
THALIDOMIDE |
|
Revlimid |
59572-402 |
59572-402-28 |
2.5 mg/1 |
CAPSULE |
ORAL |
NDA021880 |
Celgene Corp. |
Lenalidomide |
LENALIDOMIDE |
|
Revlimid |
59572-402 |
59572-402-00 |
2.5 mg/1 |
CAPSULE |
ORAL |
NDA021880 |
Celgene Corp. |
Lenalidomide |
LENALIDOMIDE |
|
Revlimid |
59572-405 |
59572-405-00 |
5 mg/1 |
CAPSULE |
ORAL |
NDA021880 |
Celgene Corp. |
Lenalidomide |
LENALIDOMIDE |
|
Revlimid |
59572-405 |
59572-405-28 |
5 mg/1 |
CAPSULE |
ORAL |
NDA021880 |
Celgene Corp. |
Lenalidomide |
LENALIDOMIDE |
|
Revlimid |
59572-410 |
59572-410-28 |
10 mg/1 |
CAPSULE |
ORAL |
NDA021880 |
Celgene Corp. |
Lenalidomide |
LENALIDOMIDE |
|
Revlimid |
59572-410 |
59572-410-00 |
10 mg/1 |
CAPSULE |
ORAL |
NDA021880 |
Celgene Corp. |
Lenalidomide |
LENALIDOMIDE |
|
Revlimid |
59572-415 |
59572-415-21 |
15 mg/1 |
CAPSULE |
ORAL |
NDA021880 |
Celgene Corp. |
Lenalidomide |
LENALIDOMIDE |
|
Revlimid |
59572-415 |
59572-415-00 |
15 mg/1 |
CAPSULE |
ORAL |
NDA021880 |
Celgene Corp. |
Lenalidomide |
LENALIDOMIDE |
|
Revlimid |
59572-420 |
59572-420-00 |
20 mg/1 |
CAPSULE |
ORAL |
NDA021880 |
Celgene Corp. |
Lenalidomide |
LENALIDOMIDE |
|
Revlimid |
59572-420 |
59572-420-21 |
20 mg/1 |
CAPSULE |
ORAL |
NDA021880 |
Celgene Corp. |
Lenalidomide |
LENALIDOMIDE |
|
Revlimid |
59572-425 |
59572-425-21 |
25 mg/1 |
CAPSULE |
ORAL |
NDA021880 |
Celgene Corp. |
Lenalidomide |
LENALIDOMIDE |
|
Revlimid |
59572-425 |
59572-425-00 |
25 mg/1 |
CAPSULE |
ORAL |
NDA021880 |
Celgene Corp. |
Lenalidomide |
LENALIDOMIDE |